Skip to search formSkip to main contentSkip to account menu

5-methylurapidil

Known as: 5-methyl-urapidil 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Background and purpose:  The expression of multiple pharmacological phenotypes including α1L‐adrenoceptor has recently been… 
Highly Cited
2006
Highly Cited
2006
To compare the in vitro human ureteric muscle response to calcium‐channel and α‐adrenoceptor antagonists, to determine the… 
Highly Cited
2003
Highly Cited
2003
Background—The &agr;1-adrenoceptor–blocking antihypertensive doxazosin has been associated with increased risk of heart failure… 
Highly Cited
2001
Highly Cited
2001
Binding affinities of serotonin (5-HT)-receptor antagonists and agonists at human recombinant alpha1-adrenoceptor subtypes… 
Highly Cited
2000
Highly Cited
2000
This study provides new information about the relative importance of different α1-adrenoceptors during norepinephrine (NE… 
Highly Cited
2000
Highly Cited
2000
Catecholamines modulate cardiac function at least in part through alpha(1)-adrenergic receptors linked to the activation of… 
1999
1999
To investigate the contractile responses mediated through α1‐adrenoceptors in human urethra and to evaluate the effectiveness of… 
1997
1997
PURPOSE To evaluate the effects of 5-methylurapidil (5-MU) on intraocular pressure (IOP) and aqueous humor dynamics in female…